Treść książki
Przejdź do opcji czytnikaPrzejdź do nawigacjiPrzejdź do informacjiPrzejdź do stopki
6
TableofContents
4.Protectionofundisclosedinformation
/56
5.Trademarkprotectioninthecontextofbordercontrolmeasures/60
6.Summary
/66
ChapterTwo
MeasuresforincreasingaccesstomedicinalproductsaspartoftheWorld
TradeOrganizationsystemofintellectualpropertyprotection
/69
1.Introductoryremarks
/69
2.Flexibilities-conceptandattemptatclassification
/70
3.Teimportanceoftheinterpretationandimplementationofthe
TRIPSAgreement
3.1.Generalcomments
/73
/73
3.2.Problemsofdevelopingcountries-DeclarationontheTRIPS
AgreementandPublicHealth
/79
3.2.1.Antecedents
3.2.2.Declarationtext
3.2.3.Assessmentattempt
/79
/85
/92
4.Exclusionfrompatentability
/94
5.Fairuseofothers’inventions
/95
5.1.Generalcomments
/95
5.2.TeCanada-PatentProtectionofPharmaceuticalProducts
(DS114)dispute
5.2.1.Disputebackground
/97
/97
5.2.2.Disputeparties’positions
/99
5.2.3.ReportofthePanel
/103
5.2.4.Concludingremarks
/108
6.Compulsorylicensing
6.1.Generalcomments
/109
/109
6.2.Reasonsandconditionsforissuingcompulsorylicenses/112
6.3.Teproblemofinsufcientmanufacturingcapacities
/121
6.3.1.Problemoutline
/121
6.3.2.Courseofnegotiations
/122
6.3.3.DecisionoftheGeneralCouncilofAugust30,2003/127
6.4.Concludingremarks
6.3.4.Assessmentattempt
/136
/133
